These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 6924817

  • 21. Methods for determination of prekallikrein in plasma, glandular kallikrein and urokinase.
    Claeson G, Friberger P, Knös M, Eriksson E.
    Haemostasis; 1978; 7(2-3):76-8. PubMed ID: 26629
    [Abstract] [Full Text] [Related]

  • 22. Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
    Lämmle B, Tran TH, Ritz R, Duckert F.
    Am J Clin Pathol; 1984 Oct; 82(4):396-404. PubMed ID: 6206713
    [Abstract] [Full Text] [Related]

  • 23. Assay of total factor XII and of activated factor XII in plasma with a chromogenic substrate.
    Vinazzer H.
    Thromb Res; 1979 Jan; 14(1):155-66. PubMed ID: 425078
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Factor XII deficiency - Hageman trait. Additional diagnostic procedures].
    Martinić P.
    Bilt Hematol Transfuz; 1979 Jan; 7(2-3):151-8. PubMed ID: 263755
    [Abstract] [Full Text] [Related]

  • 30. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M, Ercoreca L, Lucia JF, Giralt M, Raichs A.
    Thromb Haemost; 1979 Dec 21; 42(4):1286-8. PubMed ID: 261563
    [Abstract] [Full Text] [Related]

  • 31. Determination of factor XII in plasma using the kallikrein substrate chromozym PK.
    Klessen C, Stürzebecher J, Markwardt F.
    Thromb Res; 1982 Mar 15; 25(6):501-5. PubMed ID: 6921902
    [No Abstract] [Full Text] [Related]

  • 32. Analyses of factor XII, prekallikrein and kallikrein inhibitory capacity in patients with laboratory signs of DIC.
    Egberg N, Hellgren M.
    Scand J Clin Lab Invest Suppl; 1985 Mar 15; 178():25-9. PubMed ID: 3867118
    [Abstract] [Full Text] [Related]

  • 33. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ, Kortmann JH.
    Thromb Haemost; 1987 Dec 18; 58(4):1040-2. PubMed ID: 3445224
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of the clotting defect in a factor XII-deficient kindred.
    Chistolini A, Mazzucconi MG, Motta M, Solinas S, Tirindelli MC, Mariani G.
    Ric Clin Lab; 1985 Dec 18; 15(3):241-5. PubMed ID: 3853270
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. High prekallikrein levels during pregnancy.
    Marcel GA, Caspar C, Sabatier C, Gautray J, Schirar A.
    Pathol Biol (Paris); 1975 Dec 18; 23 suppl():66-8. PubMed ID: 772561
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prekallikrein deficiency in a family of miniature horses.
    Turrentine MA, Sculley PW, Green EM, Johnson GS.
    Am J Vet Res; 1986 Nov 18; 47(11):2464-7. PubMed ID: 3641551
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.